Codes / ICD10CM / D02.1

D02.1 Carcinoma in situ of trachea

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Carcinoma in situ of trachea
  • Also known as CIS of the trachea or tracheal carcinoma in situ.

Summary

Carcinoma in situ of the trachea refers to a precancerous condition where abnormal cells are found in the tissue lining the trachea. These cells have the potential to become cancerous but have not yet invaded surrounding tissues.

Causes

The exact cause of carcinoma in situ of the trachea is unclear, but it may be linked to genetic mutations triggered by environmental and lifestyle factors such as smoking, chronic inflammation, or exposure to carcinogens.

Risk Factors

  • Smoking: Major risk factor due to exposure to carcinogens.
  • Chronic respiratory conditions: Such as chronic bronchitis or recurrent tracheal irritation.
  • Occupational hazards: Exposure to chemicals, asbestos, or pollutants.
  • Age: More common in older adults.
  • Gender: Males are more frequently affected.

Symptoms

  • Persistent cough or chronic cough.
  • Hoarseness or voice changes.
  • Shortness of breath or wheezing.
  • Unexplained chest discomfort.

Diagnosis

Diagnosis involves visual examination of the trachea (e.g., bronchoscopy) to identify abnormal tissue. A biopsy of the affected area is typically performed to confirm the presence of carcinoma in situ. Imaging studies like CT scans may be used to assess the extent of the lesion.

Treatment Options

  • Surgery: Removal of the affected tissue can prevent progression to invasive cancer.
  • Radiation therapy: May be employed if surgery is not feasible or to treat residual disease.
  • Close monitoring: Regular follow-up with imaging and endoscopic evaluations to detect recurrence.

Prognosis and Follow-Up

Prognosis is generally favorable if detected early and treated appropriately. Follow-up care includes periodic bronchoscopies and imaging to monitor for recurrence or progression. Long-term surveillance is recommended due to the risk of developing invasive cancer.

Complications

  • Progression to invasive tracheal cancer if left untreated.
  • Airway obstruction from tumor growth.
  • Recurrence after treatment.

Lifestyle & Prevention

  • Avoid smoking and second-hand smoke exposure.
  • Minimize exposure to occupational carcinogens (e.g., asbestos, chemicals).
  • Manage chronic respiratory conditions to reduce inflammation.
  • Maintain a healthy lifestyle to support overall respiratory health.

When to Seek Professional Help

Seek medical attention if you experience persistent cough, hoarseness, shortness of breath, or unexplained chest discomfort, especially if you have risk factors like smoking or occupational exposure.

Tips for Medical Coders

Document the diagnosis with the specific code D02.1 for carcinoma in situ of the trachea. Ensure clinical documentation supports the precancerous nature of the lesion and confirms no invasion of surrounding tissues. Include details of diagnostic procedures (e.g., bronchoscopy, biopsy) and treatment plans to justify coding accuracy.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

D02.1 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.